Lupus Nephritis Treatment Market is segmented By Treatment Type (Immunosuppressants, Biologics), By Route of Administration (Intravenous, Oral, Subcutaneous), By Patient ....
Market Size in USD
CAGR8.4%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 8.4% |
Market Concentration | Medium |
Major Players | Roche, AstraZeneca, Novartis, Aurinia Pharmaceuticals, GlaxoSmithKline |
The lupus nephritis treatment market is estimated to be valued at USD 1.95 billion in 2024 and is expected to reach USD 3.42 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.4% from 2024 to 2031. The increasing prevalence of systemic lupus erythematosus and growing awareness about the availability of various treatment options are expected to drive the growth of the market during the forecast period.